Informações:
Falhas:
ID
15410
Descrição
Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT02396043
Link
https://clinicaltrials.gov/show/NCT02396043
Palavras-chave
Versões (1)
- 30/05/2016 30/05/2016 -
Transferido a
30 de maio de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Lymphoma, Lymphoblastic NCT02396043
Eligibility Lymphoma, Lymphoblastic NCT02396043
- StudyEvent: Eligibility
Similar models
Eligibility Lymphoma, Lymphoblastic NCT02396043
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Lymphoblastic T-cell lymphoma
Item
newly diagnosedt-lbl
boolean
C2853920 (UMLS CUI [1])
Age
Item
age:18-65years
boolean
C0001779 (UMLS CUI [1])
Ann Arbor lymphoma staging system
Item
ann arbor stage ieto stage ive
boolean
C0432516 (UMLS CUI [1])
Measurable lesion
Item
at lease one measurable lesion
boolean
C1513041 (UMLS CUI [1])
Chemotherapy Regimen Firstly | Therapeutic radiology procedure Firstly
Item
receive no chemotherapy or radiotherapy before
boolean
C0392920 (UMLS CUI [1,1])
C1279901 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C1279901 (UMLS CUI [2,2])
C1279901 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C1279901 (UMLS CUI [2,2])
Renal function | Creatinine measurement, serum | Creatinine clearance measurement | Liver function | Bilirubin, total measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
adequate renal function (eg, serum creatinine≤1.5 mg/dl and creatinine clearance ≥50 ml minute), and hepatic function (e.g, total bilirubin≤ 2 times the upper limit of normal and aspartate and alanine transaminase levels ≤ 3 times the upper limit of normal)
boolean
C0232804 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0373595 (UMLS CUI [3])
C0232741 (UMLS CUI [4])
C0201913 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
C0201836 (UMLS CUI [7])
C0201976 (UMLS CUI [2])
C0373595 (UMLS CUI [3])
C0232741 (UMLS CUI [4])
C0201913 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
C0201836 (UMLS CUI [7])
Mismatch Inclusion criteria
Item
mismatch the inclusion criteria
boolean
C1881865 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C1512693 (UMLS CUI [1,2])
Central Nervous System Involvement systematic | Malignant Neoplasms | Comorbidity Compliance behavior Limited
Item
systematic central nervous system involvement, previous or concomitant malignancies and any coexisting medical problems that could cause poor compliance with the study protocol.
boolean
C3714787 (UMLS CUI [1,1])
C1314939 (UMLS CUI [1,2])
C0220922 (UMLS CUI [1,3])
C0006826 (UMLS CUI [2])
C0009488 (UMLS CUI [3,1])
C1321605 (UMLS CUI [3,2])
C0439801 (UMLS CUI [3,3])
C1314939 (UMLS CUI [1,2])
C0220922 (UMLS CUI [1,3])
C0006826 (UMLS CUI [2])
C0009488 (UMLS CUI [3,1])
C1321605 (UMLS CUI [3,2])
C0439801 (UMLS CUI [3,3])